Single-Dose Radiotherapy to Prevent Metastasis in Mesothelioma
Author Information
Author(s): Bydder S, Phillips M, Joseph D J, Cameron F, Spry N A, DeMelker Y, Musk A W
Primary Institution: Sir Charles Gairdner Hospital, Perth, Australia
Hypothesis
Does a single dose of radiotherapy reduce procedure tract metastasis in patients with malignant pleural mesothelioma?
Conclusion
The study found no significant difference in procedure tract metastasis between the radiotherapy and control groups.
Supporting Evidence
- Chest wall seeding occurs in 19% of patients following thoracoscopy.
- Previous studies showed that a three-fraction course of radiotherapy reduced metastasis to 0%.
- The median survival from randomisation was 8.7 months, with a 1-year survival of 35%.
- Only seven patients remained alive at the end of the study.
Takeaway
Doctors tested if one dose of radiation could stop cancer from spreading after procedures, but it didn't work.
Methodology
Patients were randomized to receive either a single dose of radiotherapy or no treatment, and followed for metastasis development.
Limitations
The study did not demonstrate a benefit from the single dose of radiotherapy, and the radiation dose used may have been insufficient.
Participant Demographics
The study included 43 patients with a mean age of 70 years, predominantly male (93%).
Statistical Information
P-Value
0.53
Statistical Significance
p=0.53
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website